Frederick Maloisel
1Patents
1h-index
4Co-inventors
25Inventor score
Filing activity: Mar 27, 2003 → Mar 27, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6987103B2 | Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents | Human Necessities | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.